Animal Models to Test SARS-CoV-2 Vaccines: Which Ones Are in Use and Future Expectations

Full text
Author(s):	Lima, Gabrielle Gimenes ; Portilho, Amanda Izeli ; De Gaspari, Elizabeth Total Authors: 3
Document type:	Journal article
Source:	PATHOGENS; v. 12, n. 1, p. 16-pg., 2023-01-01.
Abstract
Since late 2019 and early 2020, with the emergence of the COVID-19 pandemic, scientists are rushing to develop treatment and prevention methods to combat SARS-CoV-2. Among these are vaccines. In view of this, the use of animals as experimental models, both to investigate the immunopathology of the disease and to evaluate the efficacy and safety of vaccines, is mandatory. This work aims to describe, through recent scientific articles found in reliable databases, the animal models used for the in vivo testing of COVID-19 vaccines, demonstrating some possibilities of more advantageous/gold-standard models for SARS-CoV-2 vaccines. The majority of the studies use rodents and primates. Meanwhile, the most adequate model to be used as the gold standard for in vivo tests of COVID-19 vaccines is not yet conclusive. Promising options are being discussed as new tests are being carried out and new SARS-CoV-2 variants are emerging. (AU)

FAPESP's process:	18/04202-0 - Study of the immunogenicity of outer membrane antigens of Neisseria meningitidis and interaction with cationic lipids: evaluation of new adjuvant for Neisseria meningitidis in different strains of elderly mice
Grantee:	Elizabeth Natal de Gaspari
Support Opportunities:	Regular Research Grants